KUMC Neurology Team set for ALS fundraising walk
On Saturday, Sept. 17, the KUMC Neurology Team will join hundreds of walkers at Arrowhead Stadium for the ALS Association's Walk to Defeat ALS. This is the organization's biggest annual event, which raises funds that allow local chapters to sustain care services and support research for much of the next year. This year's goal for the local event is $432,000.
Visit the neurology team's website to make a donation.
NIH Medical Research Scholars Program
The MRSP is a yearlong research training program designed to attract creative, research-oriented medical, dental, and veterinary students to the NIH intramural campus in Bethesda, MD. It is intended for rising fourth-year students (initial clinical rotations completed), but does not exclude second-year students in medical school who have strong research interests from applying. Students engage in a mentored basic, clinical, or translational research project that matches their professional interests, and research and career goals. Their research experiences are supplemented by academic activities featuring lectures by world-renowned scientists, clinical rounds featuring research patients from the NIH Clinical Center, and an interactive Journal Club addressing major issues in clinical research.
Applications will be accepted for the 2017-2018 MRSP class beginning October 1, 2016, and the deadline for complete applications is January 15, 2017.
Visit the website for more information: http://www.cc.nih.gov/training/mrsp/index.html
Questions may be addressed to email@example.com
Fourth Annual Fall Symposium: Neurogenetics
Provided by the University of Iowa Health Care Department of Neurology and University of Iowa Roy J. and Lucille A. Carver College of Medicine
For neurologists, healthcare providers, allied health workers, residents (current and former), fellows and students.
September 30, 2016 (symposium check-in begins at 7:30 a.m.)
University of Iowa Hospitals and Clinics
Damasio Conference Room (Elevator C, Level 7)
The translational scientists who will be the faculty of this meeting are in the forefront of developing therapies to help treat neurogenetic disorders. These therapies will eventually become worldwide standards for neurogenetics. Following the symposium, attendees should be able to: identify neurogenetic disease of the brain, spinal cord, nerve and muscle; utilize the current standards of care for managing these disorders; describe how to diagnose and differentiate these disorders in a rational manner; discuss the clinical presentation and management of genetic diseases of the brain, spinal cord, nerve and muscle; explain advances in translational science for these neurogenetic dissorders; review the underlying etiologies for these disorders and approaches to treatment; and evaluate patients and families with neurogenetic conditions.
Fourth Annual Midwest Conference on Cell Therapy and Regenerative Medicine
September 16-17, 2016
Sheraton Hotel, Overland Park, Kansas
Sponsored by Midwest Stem Cell Therapy Center and University of Kansas Medical Center Continuing Education and Professional Development
This conference is designed to update physicians, scientists, nurses and other health care professionals and trainees, as well as the general public, on the past, present and future of adult stem cell therapy and new developments in adult stem cell research. It will also address diagnosis and treatment guidelines related to cell therapy for various medical conditions, management of patients using these new cell transplantation technologies and the ethical use of regulated adult stem cells.
New England Journal of Medicine publishes study co-authored by Department of Neurology Chairman Richard Barohn, M.D.
Department of Neurology Chairman Richard Barohn, M.D., was published in the New England Journal of Medicine as an author of "Randomized Trial of Thymectomy in Myasthenia Gravis."
"Removal of the thymus gland has been a mainstay in the treatment of myasthenia gravis, but there is no conclusive evidence of its benefit," the authors wrote. "We conducted a multicenter, randomized trial comparing thymectomy plus prednisone with prednisone alone."
The clinical trial provided evidence supporting the use of thymectomy for improving clinical outcomes and reducing the need for immunosuppressive therapy in patients with myasthenia gravis. Over a period of three years, thymectomy was associated with a more favorable outcome than was prednisone alone. The randomized, medication-controlled, rater-blinded trial also showed a benefit of thymectomy with respect to requirements for prednisone and azathioprine therapy, the number of symptoms and the distress level related to immunosuppressive agents, and the need for hospitalization to manage disease exacerbations.
New Research & Discovery Grand Rounds Series Will Meet Training Requirements
All individuals involved in the design, conduct or reporting of research are now required to complete training on the Responsible Conduct of Research through a combination of online and in-person formats. A series of Research & Discovery Grand Rounds to be held at KU Medical Center starting September 7 will qualify to meet the live format requirements.
Plagiarism is the topic for the September 7 R&D Grand Rounds to be held from 12-1 p.m. in Clendening Auditorium.
International publication includes interview with Dr. Russell Swerdlow, Alzheimer's Disease Center director
Russell Swerdlow, M.D., Director of the Alzheimer's Disease Center at the University of Kansas Medical Center, was featured in an August 15 International Business Times article about the obstacles to understanding and curing Alzheimer's disease. He discussed how his team's approach differs from that of many other researchers.
Dr. Swerdlow's hypothesis is that amyloid plaques and tau tangles are not drivers of the disease, but symptoms. "I think the problem lies in changes in brain energy metabolism and mitochondria," he told the magazine. He and his colleagues are looking at how energy metabolism changes in other tissues of the body, such as muscles. Since more mitochondria are created in muscles when people exercise, understanding these changes could enhance efforts to create a drug that similarly affects the brain.
Visit the International Business Times to read the complete article.
Kansas City University Science Friday
"Duchenne Muscular Dystrophy Gene Therapy" is the subject of the next Kansas City University Science Friday talk on August 26 in Ricci Auditorium at Kansas City University of Medicine and Biosciences. The speaker will be Dr. Dongsheng Duan, the Margaret Proctor Mulligan Professor in Medical Research, Molecular Microbiology and Immunology at the University of Missouri School of Medicine, Columbia, Missouri.
For more information and to register, click here.
"Subject Recruitment: The Ever-evolving Process" Webinar
A free educational webinar on subject recruitment will be held from noon to 1 p.m. July 27. Hosted by Complion, the presentation by Chris Trizna, President of CSSi, will help attendees dissect challenges and barriers associated with patient recruitment, enrollment and retention. Trizna will also discuss the best and worst recruitment techniques through traditional advertising and social media. Registered attendees will receive a certificate of attendance for self-reporting continuing education credits.
For more information and to register, click here.
Randolph Nudo appointed director of the Institute for Neurological Discovery
Randolph J. Nudo, Ph.D., has been appointed director of the Institute for Neurological Discovery at KU Medical Center. Nudo will replace Peter Smith, Ph.D., who served as the institute's founding director since 2009. Smith is stepping down to devote more time to his role as senior associate dean for research at the KU School of Medicine. Smith is also a professor of molecular and integrative physiology and co-director of the Kansas Intellectual and Developmental Disabilities Research Center.
Nudo is vice chairman of research in the Department of Rehabilitation Medicine, the director of the Landon Center on Aging, and the Marion Merrell Dow Distinguished Professor in Aging. He has been on the faculty at KU Medical Center since 1997. Read more.
Goodbye to the Neurology Class of 2016
The residents and Dr. Dubinsky say good bye to Drs. Dowell, Murphy, Reynders and Baumagardner (not present) during the final morning report of the academic year.
Congratulations 2016 graduates!
Ziegler Professorship Lecture
The 10th annual Gertrude and Dewey Ziegler Professorship lecture was given by James C. Grotta, M.D., Director of Stroke Research, Clinical Institute for Research and Innovation at Memorial Hermann - Texas Medical Center. Dr. Grotta discussed the current level of success in treating acute ischemic stroke as well as the potential for a hugely beneficial transformation in treatment with the introduction of mobile stroke treatment units. See photos of Ziegler Professorship lecture and related events.
National Institutes of Health Collaboratory Grand Rounds Webinar
Rethinking Clinical Research
"The CTSA Trial Innovation Network: Early Vision and Goals"
Speaker: Monica Shah, M.D.
Director, CTSA Trial Innovation Network
National Center for Advancing Translational Sciences (NCATS)
Friday, June 03
12:00 PM-1:00 PM.
To join the online meeting:
1. Log in to the URL first.
2. Click 'Audio Conference'
3. Choose 'I will call in', select the Toll Free number.
4. Dial in using the information from the dialog box that appears.
Be certain to use the Access Code AND the Attendee ID.
If the URL above does not work, go to dukemed.webex.com and enter:
Meeting Number: 739 348 059
Meeting Password: 1234
For Audio ONLY:
Call-in toll-free number (US/Canada): 1-855-244-8681
Access code: 739 348 059
Introduction to Biostatistics for Clinical and Translational Researchers
Four lectures on biostatistics topics relevant to clinical and translational research will be held from 9-11 a.m., July 8, 15, 22 and 29 in Clendening Auditorium. Instructor Jo A. Wick, Ph.D., will discuss topics such as designing experiments, descriptive statistics, hypothesis testing, linear regression and survival analysis. No knowledge of statistics is assumed.
The series is sponsored by the University of Kansas Medical Center Department of Biostatistics, The University of Kansas Cancer Center and Frontiers: The Heartland Institute for Clinical and Translational Research.
Registration is free online at http://biostatistics.kumc.edu.
For additional information, contact Jo A. Wick at firstname.lastname@example.org or (913) 588-4789.
ALS Golf Classic 2016
The 10th annual "Putting the Boots to ALS Golf Classic" is set for Saturday, June 11, at Deer Creek Golf Club, 7000 W. 133rd Street, Overland Park, Kansas 66209.
Help raise money for research to help find a cure for ALS. Proceeds from the event will continue to provide research funds to the University of Kansas and Washington University's Neuroscience Research Departments for ALS.
Lunch and hole assignments are scheduled for noon. The tournament starts at 1 p.m.
Register before June 1 for the early-bird special of $125.00. After June 1, the entry fee will be $150.00.
Donations for tournament prizes and awards are welcome, and organizers can discuss ideas for items and services to donate. For more information, contact Project 5 for ALS at (913) 909-2497.
May 12-16 is National Neuropathy Awareness Week.
More than 20,000,000, or 1 in 15-Americans are afflicted by neuropathy, many of whom do not know they have it. Even though it is one of the most common chronic neurological diseases, peripheral neuropathy is often misdiagnosed and inadequately treated. Peripheral neuropathy causes arms and leg numbness, tingling, pain, weakness, loss of coordination, and ultimately falls. Appropriate management improves the quality of life of people with neuropathy and can prevent physical disability. People in and around Kansas City and in the region have access to world renowned specialists in neuropathy.
Neuromuscular specialists of the Department of Neurology at The University of Kansas Medical Center (KUMC) are thought leaders in the field of the peripheral neuropathies. The NeuromuscularDivision continues to expand collaborations with national and international organizations to promote the best care practices for people who suffer from neuropathy. Since there are many causes for peripheral neuropathies, our neuromuscularspecialists are engaged with a variety of patient organizations focused on promoting the best care for each of the specific neuropathy types.
The GBS|CIDP Foundation International is the preeminent global non-profit organization supporting individuals and their families affected by Guillain-Barré syndrome (GBS), chronic inflammatory demyelinating polyneuropathy (CIDP), and related syndromes such as multifocal motor neuropathy (MMN) through a commitment to support, education, research, and advocacy. Based on levels of expertise, available treatments, facilities, and research capabilities, neuromuscularspecialists at the KUMC Neurology Department are designated as part of an international elite network of Centers of Excellence for people with GBS, CIDP and MMN. For more information on the GBS|CIDP Foundation International and on the Centers of Excellence, please visit https://www.gbs-cidp.org/and http://www.gbs-cidp.org/get-support/centers-of-excellence-2/and
The Foundation for Peripheral Neuropathy (FPN) is a public charity committed to fostering collaboration among today's most gifted and dedicated neuroscientistsand physicians. The FPN has established a network of leading neurological consortium partner clinics that work with each other and FPN to build the Peripheral Neuropathy Research Registry. Based on neuropathy expertise, the University of Kansas Medical Center Neuromuscular Division, led by Dr. Mazen M. Dimachkie, has become this year the sixth site participating in this important registry. For more information on FPN and Peripheral Neuropathy Research Registry, please visit https://www.foundationforpn.org/and https://www.foundationforpn.org/research/research-registry/consortium-partners/
Concurrently, the Neuromuscular Division in the Department of Neurology at the University of Kansas Medical Center was invited this year by the Hereditary NeuropathyFoundation to be the eighth Center of Excellence. This is in recognition of the Neuromuscular Division's excellence in clinical care, education and research in genetic neuropathies such as Charcot-Marie-Tooth neuropathy. According to HNF, the designated Centers of Excellence demonstrate strengths in providing excellence in clinical care and research and will collaborate with HNF to expand their role as patient community hubs for clinical care, community engagement, research, and training/education. For more information on the Hereditary Neuropathy Foundation, see http://www.hnf-cure.org/ and for a complete listing of Centers of Excellence http://www.hnf-cure.org/centersofexcellence/.
This is an exciting time for people with neuropathy. So please join us in celebrating National Neuropathy AwarenessWeek 2016.
Kansas City Neurology/Neurosurgery Society (KC CNS)
Dr. James Grotta
June 2, 2016
Annual Department Photo
June 3, 2016
The annual department photo will be taken immediately following the Zeigler Professorship Lecture on the steps of the Murphy building.
KU Medical Center named "Center of Excellence" by Hereditary Neuropathy Foundation
April 29, 2016
The Hereditary Neuropathy Foundation (HNF) has named the University of Kansas Medical Center a "Center of Excellence," one of only 10 institutions in its new national network.
HNF's intention for the COE network is to benefit the hereditary neuropathypatient community, which includes those with a rare disease called Charcot-Marie-Tooth and inherited neuropathies. KU Medical Center was chosen as a Center of Excellence for its demonstrated strengths in clinical care and research.
The HNF will collaborate with its Centers of Excellence to expand their roles as patient community hubs for clinical care, community engagement, research and training/education.
Visit the HNF website for more information.
New Research Communications Coordinator, Michelle Strausbaugh
April 20, 2016
Michelle Strausbaugh is the new Research Communications Coordinator. She is a member of the university's communications staff, and her job is to be a liaison between that department and those working day-to-day in Neurology, Frontiers, and the Research Institute.
If you have a story idea for the home page of KUMC.edu or if you are contacted by the media, she is available to help you. If you have something to communicate internally, have questions about your newsletter, or have other communication needs; Michelle can help you figure out next steps.
You can contact Michelle Strausbaugh at: (913) 945-7670 or email@example.com
MS Achievement Center Grand Opening
April 15, 2016
Thousands of people in Kansas and the greater Kansas City area are afflicted with multiple sclerosis (MS). Now they will have a new place to seek treatment and support with the new MS Achievement Center officially opening April 7th at the University of Kansas Medical Center. Read more. Photos from the event.
George Brett Award
March 4, 2016
Congratulations to Dr. Richard Barohn, the receipient of the 2016 George Brett Award for Commitment. Richard J. Barohn, MD, distinguished professor and chairman of the University of Kansas Medical Center's Department of Neurology, has been treating people living with ALS for over 30 years and was responsible for starting the ALS Association Certified Treatment Center for Excellence at the University of Kansas Medical Center.
YouTube Videos to Watch:
Epilepsy Center Receives a Level 4 Recertification
Feb. 19, 2016
The hospital's Comprehensive Epilepsy Center has been recertified at Level 4 designation, the industry's highest mark.
The designation, from the National Association of Epilepsy Centers, is for the full two years. The center was first named Level 4 in 2012 and remains one of only two Level 4 adult comprehensive epilepsy centers in the metro and the only one in Kansas.
A Level 4 epilepsy center provides:
Roughly two-thirds of patients withepilepsy can be treated successfully with a combination of medications. The remaining patients can benefit from an advanced evaluation by an epileptologist to determine if they are candidates for additional treatment options, including several available surgical procedures. (Link to epilepsy surgical pages).
The center also focuses on research and a wide range of support services, including treatment to ease psychological, social and financial issues.
The epilepsy center's outpatient clinic, which is on ground floor Delp, managed approximately 1,700 patient visits during 2015. Also during the year, 279 epilepsy patients were admitted; they are cared for on Neuroscience/ENT ICU and Neuroscience/ENT Progressive Care (HC 8-9).
Read more and see the center's team http://intranet.kumed.com/news-and-events/news/purple-day-epilepsy-2015
Life-Saving Treatment For Seizures
Nov. 23, 2015
KCTV5 News posted this video on their website highlighting the work in epilepsy treatment at the KU Medical Center. Watch the video here.
Third annual fall symposium: Neurogenetics
Oct. 9, 2015
The University of Iowa Carver College of Medicine Department of Neurology will have its 3rd annual fall symposium Oct. 9. Read more.
Kansas City Star highlights KU Medical Center's neuromuscular research program
May 3, 2015
The Kansas City Star newspaper highlighted KU Medical Center's neuromuscular research program in a series of stories, photos and videos. Read the main story and see four videos here. Read a separate story highlighting the work of Dr. Jeffrey Statland, assistant professor of neurology. Also, see the complete photo gallery.
Parkinson's Disease and Movement Disorder Center earns re-designation honor
April 30, 2015
The Parkinson's Disease and Movement Disorder Center at The University of Kansas Hospital and KU Medical Center has earned re-designation as a National Center of Excellence from the National Parkinson Foundation. Read more.
Healthy aging and the brain
November 7, 2014
The KU Alzheimer's Disease Center is sponsoring a 12-week "Smart Aging" class desinged to pass along research-based knowledge on diet and exercise that may improve and maintain brain health in seniors. Read more.
Neurology residents participate in ALS Ice Bucket Challenge
August 28, 2014
KU Medical Center neurology residents answered a challenge from the University of Virginia to participate in the ongoing Ice Bucket Challenge to benefit ALS research. Watch the video. Also, if interested, donate to support ALS research at KU Medical Center.
Dr. Russell Swerdlow named as Chancellors Club professor
August 27, 2014
Dr. Russell Swerdlow, M.D., professor of neurology and a leading expert on Alzheimer's disease and mitochondrial dysfunction, has been named as a Chancellors Club professor. He will receive a $10,000 award and will be honored at a reception in Lawrence, Kan. Read more.
Neurology/Neurosurgery ranked No. 12 in nation by U.S. News and World Report
July 15, 2014
In its third consecutive year on the list, this specialty received its highest ranking ever on the annual list. Read more.
Medical marijuana can alleviate MS symptoms
April 28, 2014
Dr. Gary Gronseth, professor and vice chairman of the department, was quoted in several media outlets, including the Boston Globe, about how medical marijuana may have benefits for patients with MS. Read more.
Hope for those with multiple sclerosis
March 5, 2014
An $800,000 grant will help KU Medical Center create a new center to help patients with multiple sclerosis. Read more.
Gift supports Alzheimer's research at KU Medical Center
February 10, 2014
A $10,000 gift from Local Union No. 124 International Brotherhood of Electrical Workers, of Kansas City, Mo., for the University of Kansas Medical Center will help fight Alzheimer's disease. Read more.
KU researcher's 'Neural Prosthesis' could help people with brain injuries
January 27, 2014
Randolph Nudo, Ph.D., director of KU's Landon Center on Aging, has been featured in the Kansas City Star for his work on a computer chip that can be implanted into the brain to improve brain function. Read more.
Russell Swerdlow, M.D., named Gene and Marge Sweeney Professor of Neurology
December 15, 2013
Russell Swerdlow, M.D., director of the University of Kansas Alzheimer's Disease Center, has been named the Gene and Marge Sweeney Professor of Neurology. Swerdlow studies brain energy metabolism and the role it plays in neurodegenerative diseases. His main area of clinical expertise includes the neurodegenerative diseases that affect cognition, especially Alzheimer's disease. The professorship was established through an estate gift created by Mr. and Mrs. Sweeney, who owned and operated the College Motel in Lawrence for 40 years.
KU Medical Center's partnership with Swope Health Services is giving minority populations better access to clinical trials
December 3, 2013
Researchers at the University of Kansas Medical Center are continuing to build on a longstanding partnership with Swope Health Services to help involve minority populations that are often vastly underrepresented in clinical and translational research studies. Read more.
KU Alzheimer's Disease Center will use $3 million grant to study the benefit of exercise
November 2, 2013
Alzheimer's disease researchers at the University of Kansas Medical Center have received $3 million from the National Institutes of Health to study the role of exercise in preventing the disease. It will be one of the first such studies in the country. Read more.
Dr. Richard J. Barohn, MD, receives University Distinguished Professorship
October 25, 2013
Dr. Richard J. Barohn, MD, Gertrude and Dewey Ziegler Professor and Chairman of the Department of Neurology at the University of Kansas Medical Center, has received a University Distinguished Professorship. Watch a video of a presentation of the award, followed by a lecture by Robert C. Griggs, a former Chairman of the Department of Neurology at the University of Rochester.
Sleep Medicine Clinic receives program accreditation
August 15, 2013
The University of Kansas Department of Neurology's Sleep Medicine Clinic in Kansas City recently received program accreditation from the American Academy of Sleep Medicine. Read more.
Providing better stroke care
July 31, 2013
A statewide initiative is training healthcare professionals across Kansas on the most effective ways to treat and respond to a stroke. Read more.
KU Med professor walks across Kansas to raise awareness, funds for stroke research
June 6, 2013
Sandra Billinger, PT, Ph.D., assistant professor in the Department of Physical Therapy and Rehabilitation, completed a 570-mile walk across the state of Kansas with her son to raise awareness and money for her stroke research. Read more.
Hope for ALS patients
April 8, 2013
KU researchers are studying the effects of the drug rasagiline in slowing ALS. Read more.
The benefits of medication
February 7, 2013
Sharon Lynch, MD, of the University of Kansas Medical Center and Jared Bruce, Ph.D., of the University of Missouri-Kansas City are collaborating on a new program to counsel multiple sclerosis patients on why they should take their medications. Read more.
KU Hospital one of first in the nation named Advanced Comprehensive Stroke Center
December 10, 2012
The University of Kansas Hospital is one of the first five healthcare facilities in the country, and the only one in the Midwest, to be recognized as an Advanced Comprehensive Stroke Center (CSC) by The Joint Commission. Read more.
KUMC neurologist earns Chancellors Club honor
October 29, 2012
Richard J. Barohn, MD, chairman of the University of Kansas Medical Center's Department of Neurology, has been named as the recipient of the 2012 Chancellors Club career research award. Read more, and click here to see a video.
Alzheimer's Disease Center, other clinical and translational research featured on KCPT program
October 11, 2012
KU Medical Center's Alzheimer's Disease Center and Frontiers: The Heartland Institute for Clinical and Translational Research were featured on KCPT's "The Local Show." Click here to see the video (story starts at about 15:30).
Help for a rare genetic disorder
October 3, 2012
A decades-old drug previously used to treat abnormal heart rhythms is showing new promise in the fight against a rare neurological disorder, according to research conducted at the University of Kansas Medical Center. Read more.
Patients come from across the globe for study at KU's Clinical Research Center
September 20, 2012
Patients are coming from as far away as New Zealandto participate in a clinical trial at the University of Kansas Medical Center - a study that is giving new hope to people with a rare genetic condition that attacks their muscles. Read more.